AP: Voluntary removal of popular cold-and-cough medications from store shelves fuels conspiracy theories
The University of Cincinnati's Michael Hegener recently contributed to an Associated Press fact check debunking a claim that cold medicines being pulled off of pharmacy shelves were part of a larger conspiracy.
An FDA advisory committee agreed unanimously in September that an ingredient called phenylephrine found in many over-the-counter cold medicines called phenylephrine doesn't work to clear nasal congestion when taken orally. Since then, some medicines containing phenylephrine as its only active ingredient have been removed from CVS store shelves.
Some on social media have raised suspicions that the medication removals are due to a larger conspiracy to force people to receive COVID-19 vaccinations, but Hegener and other health experts said the theory has no merit.
“While some may find the timing of this FDA advisory committee conclusion being released during the cold and flu season to be less than ideal, hopefully it prompts patients to speak with their health care providers about other options that may actually be more effective for them,” Hegener, an associate professor of pharmacy at UC's James L. Winkle College of Pharmacy, wrote to the AP.
Even as certain medications are being removed, there are still plenty of options for cough and cold medicines that contain other active ingredients that are still effective. While these medications help treat symptoms like congestion, they do not prevent illness like a flu vaccine would.
Featured photo at top of woman looking at over the counter medicine in a pharmacy aisle. Photo/iStock/SDI Productions.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.